MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 255 filers reported holding MYRIAD GENETICS INC in Q2 2016. The put-call ratio across all filers is 3.30 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $1,382,000 | +0.4% | 50,745 | +5.5% | 0.95% | -4.3% |
Q3 2019 | $1,377,000 | +8.0% | 48,113 | +4.8% | 1.00% | +12.5% |
Q2 2019 | $1,275,000 | -4.4% | 45,903 | +14.2% | 0.88% | -14.7% |
Q1 2019 | $1,334,000 | +13.5% | 40,185 | -0.6% | 1.04% | +0.4% |
Q4 2018 | $1,175,000 | -36.0% | 40,426 | +1.2% | 1.03% | -25.8% |
Q3 2018 | $1,836,000 | +4.9% | 39,929 | -14.8% | 1.39% | +9.4% |
Q2 2018 | $1,751,000 | +26.1% | 46,856 | -0.3% | 1.27% | +17.8% |
Q1 2018 | $1,389,000 | -53.8% | 46,989 | -46.3% | 1.08% | -11.0% |
Q4 2017 | $3,008,000 | +116.9% | 87,554 | +93.1% | 1.21% | -16.0% |
Q2 2016 | $1,387,000 | +1.2% | 45,341 | +23.8% | 1.45% | -0.3% |
Q1 2016 | $1,371,000 | -7.7% | 36,619 | +5.3% | 1.45% | -13.2% |
Q4 2015 | $1,486,000 | +11.1% | 34,783 | -3.3% | 1.67% | +12.4% |
Q3 2015 | $1,338,000 | +13.8% | 35,952 | +4.0% | 1.49% | +21.8% |
Q2 2015 | $1,176,000 | -51.9% | 34,569 | -51.7% | 1.22% | +4.8% |
Q1 2015 | $2,444,000 | +96.1% | 71,510 | +95.5% | 1.17% | -0.3% |
Q4 2014 | $1,246,000 | – | 36,580 | – | 1.17% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Camber Capital Management LP | 2,750,000 | $75,900,000 | 2.61% |
PFM Health Sciences, LP | 2,025,681 | $55,909,000 | 1.90% |
Tieton Capital Management, LLC | 118,456 | $3,269,000 | 1.83% |
Altium Capital Management LP | 190,000 | $5,244,000 | 1.45% |
DISCIPLINED GROWTH INVESTORS INC /MN | 1,846,490 | $50,963,000 | 1.03% |
EARNEST PARTNERS LLC | 6,316,365 | $174,332,000 | 1.01% |
Glenview Capital Management | 1,679,747 | $46,361,000 | 0.99% |
Zebra Capital Management LLC | 14,209 | $392,000 | 0.63% |
AIMZ Investment Advisors, LLC | 44,185 | $1,220,000 | 0.48% |
Phocas Financial Corp. | 132,101 | $3,646,000 | 0.46% |